-
Mashup Score: 2Weight loss surgery more ‘cost saving’ over long term vs. semaglutide for class II obesity - 13 hour(s) ago
Endoscopic sleeve gastroplasty was more cost-effective and sustained greater weight loss over 5 years compared with semaglutide for patients with class II obesity, according to data published in JAMA Network Open. “Endoscopic sleeve gastroplasty (ESG) is the most effective endoscopic bariatric and metabolic therapy that is attracting attention worldwide,” Muhammad Haseeb, MD,
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 3Nearly 60 million individuals aged 45 to 85 years are eligible for CRC screening in the US - 17 hour(s) ago
Researchers estimated that nearly 60 million individuals aged 45 to 85 years are at average-risk for colorectal cancer and eligible for screening in the U.S., according to cross-sectional study data in JAMA Network Open. “Over the last decade, there have been a number of significant advancements and changes surrounding colorectal cancer screening,” Derek W. Ebner, MD, of the division
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Budesonide does not affect engraftment, clinical response after FMT in ulcerative colitis - 20 hour(s) ago
Pretreatment with budesonide did not significantly influence engraftment among patients with ulcerative colitis who underwent fecal microbiota transplantation, with researchers reporting that clinical response appeared to be donor-dependent. “Several studies addressed the effects of FMT for UC, showing a response rate of around 36% for patients with various treatment regimens,”
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2Family planning in IBD: ‘It is our responsibility’ to share accurate resources, support - 21 hour(s) ago
A young woman, newly diagnosed with inflammatory bowel disease, sits in your office. Although she is relieved to finally have a diagnosis and a plan to treat her terrifying gastrointestinal symptoms, everything about her future now seems uncertain, including her plans to become a parent. “What ifs” and catastrophic scenarios race through her mind: She’ll never be able to
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1
More than 1,600 health care professionals celebrated the approval of Rezdiffra, the first treatment for adults with metabolic dysfunction-associated steatohepatitis, according to a global online conversation analysis by Creation Healthcare. Rezdiffra (resmetirom, Madrigal Pharmaceuticals) was granted accelerated approval by the FDA on March 14, and became available to U.S. pharmacies on April 9.
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 3GLP1-RAs linked to notably higher rate of retained gastric contents during upper endoscopy - 2 day(s) ago
More than 9% of patients on glucagon-like peptide-1 receptor agonists who underwent esophagogastroduodenoscopy had retained gastric contents, although the risk for aspiration remained low, according to study results. Further, same-day colonoscopy was reported to reduce retained gastric contents, supporting the AGA’s recent clinical practice update that recommends implementation of a liquid
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1VIDEO: H. pylori eradication may ‘reduce burden of gastric cancer’ among vulnerable groups - 2 day(s) ago
In a Healio video exclusive, Shria Kumar, MD, MSCE, discusses how community-based eradication of Helicobacter pylori infection may reduce the risk for gastric cancer in historically underrepresented communities and other vulnerable groups. “H. pylori is a cause of gastric cancer,” Kumar, a gastroenterologist and clinical epidemiologist at the University of Miami Miller School of
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2Weight loss surgery more ‘cost saving’ over long term vs. semaglutide for class II obesity - 2 day(s) ago
Endoscopic sleeve gastroplasty was more cost-effective and sustained greater weight loss over 5 years compared with semaglutide for patients with class II obesity, according to data published in JAMA Network Open. “Endoscopic sleeve gastroplasty (ESG) is the most effective endoscopic bariatric and metabolic therapy that is attracting attention worldwide,” Muhammad Haseeb, MD,
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Vonoprazan noninferior to PPIs in preventing 30-day rebleeding in high-risk peptic ulcers - 3 day(s) ago
Vonoprazan was noninferior to high-dose IV proton pump inhibitor therapy in preventing 30-day rebleeding among patients with high-risk peptic ulcer bleeding who had achieved endoscopic hemostasis, according to data. “Efficacy of vonoprazan has been demonstrated as noninferior to PPIs in various acid-related diseases, including erosive esophagitis, Helicobacter pylori eradication therapy,
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Food insecurity boosts fibrosis odds in HIV with diabetes, lowers MASLD odds in HIV alone - 3 day(s) ago
Food insecurity was associated with lower odds of metabolic dysfunction-associated steatotic liver disease among patients with HIV, although the presence of diabetes increased the odds of fibrosis in this population, according to data. “Food insecurity is an independent risk factor for NAFLD and liver fibrosis and associated with greater all-cause mortality and health care utilization
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
According to data 📈 from @JAMANetworkOpen: #Endoscopicsleevegastroplasty was more cost-effective and sustained greater weight loss over 5️⃣ years compared with #semaglutide 💊 for patients with class II #obesity. Learn more ⬇️ https://t.co/ufg2S9b6t8